D441 Medical Dosage Calculations and Pharmacology - Set 3 - Part 1

Correct Answer: Increased appetite and gradual weight gain

red man syndrome is characterized by flushing, pruritus, and hypotension resulting from a rapid vancomycin infusion, which triggers a histamine release rather than a true allergic response. Option a is incorrect because anaphylaxis involves hives, tachycardia, angioedema, and wheezing or difficulty breathing, which differs from the flushing and pruritus pattern caused by rapid vancomycin infusion rate. Option b is incorrect because nephrotoxicity involves rapid loss of kidney function and would present with changes in urine output or elevated creatinine levels, not with flushing and itching during infusion. Option d is incorrect because ototoxicity from vancomycin causes tinnitus and inner ear damage affecting hearing and balance, and would not present as facial flushing and widespread pruritus during infusion.

Correct Answer: To observe for swelling, pain, and redness

standard nursing protocol requires monitoring vancomycin patients for thirty minutes after infusion begins to detect early signs of infusion-related reactions including swelling, pain, and redness at the site. Option b is incorrect because ototoxicity from vancomycin develops over time with prolonged use and would not typically manifest during the initial thirty-minute monitoring window immediately after starting an infusion. Option c is incorrect because nephrotoxicity is assessed through laboratory values over the course of therapy, not through direct bedside observation during the initial thirty-minute post-infusion monitoring period. Option d is incorrect because confusion and appetite loss are associated with digoxin toxicity rather than vancomycin administration, and would not be the primary focus during the immediate post-infusion monitoring window.

Correct Answer: Angioedema with wheezing present

angioedema, which involves swelling of deeper skin layers, combined with wheezing and difficulty breathing are hallmark signs of a true allergic reaction rather than red man syndrome. Option a is incorrect because flushing and pruritus on the face are classic presentations of red man syndrome caused by rapid vancomycin infusion, not indicators of a true allergic reaction requiring different intervention. Option b is incorrect because nausea and hypotension can occur in both red man syndrome and true allergic reactions, making this combination insufficient to differentiate between the two conditions during clinical assessment. Option c is incorrect because a red rash on the extremities is a feature commonly seen in red man syndrome due to histamine release from rapid infusion, and alone does not distinguish it from allergic response.

Correct Answer: Ototoxicity

tinnitus, or persistent ringing in the ears, along with balance disturbances are classic signs of ototoxicity, which involves inner ear poisoning and damage from prolonged vancomycin therapy. Option a is incorrect because red man syndrome presents with flushing, pruritus, and hypotension during or shortly after vancomycin infusion, not with persistent ringing in the ears or unsteadiness when walking. Option c is incorrect because nephrotoxicity involves rapid decline in kidney function with changes in urine output and elevated renal lab values, and does not typically cause tinnitus or balance problems. Option d is incorrect because superinfection development would present with new signs of infection such as diarrhea from Clostridioides difficile, not with auditory symptoms like ringing in the ears or unsteadiness.

Correct Answer: Nephrotoxicity

nephrotoxicity causes rapid loss in kidney function, which is evidenced by rising creatinine levels and decreased urine output, both of which are critical monitoring parameters during vancomycin therapy. Option b is incorrect because red man syndrome is an infusion-related reaction presenting with flushing, itching, and hypotension during rapid vancomycin administration, and does not cause changes in creatinine or urine output. Option c is incorrect because ototoxicity from vancomycin affects the inner ear, causing tinnitus and balance disturbances, and would not result in elevated creatinine levels or decreased urine output in the patient. Option d is incorrect because allergic anaphylaxis presents acutely with hives, tachycardia, angioedema, and respiratory distress rather than gradual changes in kidney function markers like creatinine and urine output.

Correct Answer: PTT checked every six hours

heparin therapy requires monitoring partial thromboplastin time every six hours to ensure therapeutic anticoagulation within the target range of forty-six to seventy seconds for safe treatment. Option a is incorrect because INR is the laboratory value monitored for warfarin therapy with a target range of two to three, not for heparin, which uses partial thromboplastin time as its primary monitoring parameter. Option b is incorrect because while hemoglobin monitoring may detect bleeding complications, it is not the primary lab used to guide heparin dosing or assess therapeutic effectiveness of anticoagulation in this patient. Option c is incorrect because although platelet counts are important to monitor for heparin-induced thrombocytopenia, the primary lab for assessing heparin therapeutic levels is partial thromboplastin time checked every six hours.

Correct Answer: Vitamin K administration

vitamin K is the established antidote for warfarin and works by restoring clotting factor production that warfarin inhibits, thereby reversing the anticoagulant effect during dangerous bleeding episodes. Option a is incorrect because protamine sulfate is the antidote specifically used to reverse the effects of heparin, not warfarin, and would not restore the clotting factors that warfarin therapy suppresses. Option c is incorrect because naloxone is the antidote for opioid overdose that reverses respiratory depression and sedation, and has no effect on anticoagulation or bleeding caused by warfarin therapy. Option d is incorrect because while fresh frozen plasma may be used as adjunctive therapy in emergencies, vitamin K is the primary identified antidote for warfarin reversal and should be recognized as such.

Correct Answer: Heparin acts fast while warfarin is slow

heparin is a fast-acting anticoagulant used for immediate clot prevention in acute settings, while warfarin is a slow-acting oral anticoagulant used for lifelong maintenance therapy. Option a is incorrect because neither heparin nor warfarin dissolves existing blood clots, as both medications work to prevent new clot formation, which is a critical distinction for nurses to understand and teach patients. Option b is incorrect because warfarin is a slow-acting anticoagulant used for long-term maintenance therapy, not acute treatment situations, where the fast-acting properties of heparin make it the preferred choice. Option d is incorrect because heparin is monitored using partial thromboplastin time every six hours, while INR monitoring with a target range of two to three is specifically associated with warfarin therapy management.

Correct Answer: Protamine sulfate

protamine sulfate is the specific antidote for heparin that reverses its anticoagulant effects, and would be the appropriate intervention for a patient showing signs of active bleeding during therapy. Option b is incorrect because vitamin K is the antidote for warfarin, not heparin, and would not effectively reverse the anticoagulant properties of heparin in a patient experiencing gum bleeding and extensive bruising. Option c is incorrect because naloxone is used exclusively to reverse the effects of opioid medications such as morphine and fentanyl, and has no role in managing bleeding complications from anticoagulant therapy. Option d is incorrect because epinephrine autoinjectors are used for severe allergic reactions and anaphylaxis, not for reversing bleeding caused by heparin therapy, which requires the specific antidote protamine sulfate.

Correct Answer: Increased risk of active bleeding

an INR of four point five significantly exceeds the therapeutic range of two to three for warfarin, indicating excessive anticoagulation that places the patient at greatly increased risk for bleeding complications. Option a is incorrect because subtherapeutic anticoagulation would be indicated by an INR below the target range of two to three, whereas an INR of four point five indicates the opposite problem of excessive anticoagulation. Option b is incorrect because a new deep vein thrombosis would be a concern if the INR were below the therapeutic range, suggesting insufficient anticoagulation, not when the INR is elevated well above the target. Option c is incorrect because pulmonary embolism risk increases when anticoagulation is inadequate with a low INR, not when the INR is elevated to four point five indicating excessive blood-thinning effects.

Correct Answer: Administer naloxone as prescribed

a respiratory rate below twelve with difficulty arousing the patient indicates opioid-related central nervous system depression, which requires immediate administration of naloxone as the opioid reversal agent. Option a is incorrect because stool softeners address opioid-induced constipation, a long-term side effect, and would not be the priority intervention when a patient is showing signs of acute respiratory depression and excessive sedation. Option c is incorrect because repositioning addresses comfort but does not treat the life-threatening respiratory depression caused by opioid overdose, which requires pharmacological intervention with naloxone as the immediate priority. Option d is incorrect because increasing the morphine drip rate would worsen the respiratory depression and central nervous system sedation, potentially leading to respiratory arrest and death in this already compromised patient.

Correct Answer: Administer a second dose of naloxone

naloxone often requires multiple doses, and if the patient remains unresponsive after approximately three minutes following the first dose, a second dose should be administered promptly to achieve reversal. Option a is incorrect because waiting thirty minutes is too long when a patient remains unresponsive with minimal breathing after the first naloxone dose, as the protocol directs reassessment and redosing after approximately three minutes. Option b is incorrect because naloxone frequently requires multiple doses due to its short half-life of one to two hours, and discontinuing it after only one dose without attempting a second would be premature clinical action. Option d is incorrect because naloxone is the only established antidote for opioid overdose, and no alternative reversal agent exists, so administering additional doses of naloxone is the appropriate clinical response.

Correct Answer: Take twice daily on a set schedule

oxycodone for chronic pain management is administered twice daily on a scheduled or around-the-clock basis, even when the patient is not actively reporting pain, to maintain consistent relief. Option b is incorrect because extended-release oxycodone for chronic pain is prescribed on a regular schedule rather than on an as-needed basis, which would result in inconsistent pain control and potential breakthrough episodes. Option c is incorrect because every four hours as needed is a dosing pattern associated with short-acting pain medications, not the extended-release formulation of oxycodone designed for scheduled twice-daily chronic administration. Option d is incorrect because once-daily bedtime dosing does not match the pharmacological profile of oxycodone for chronic pain, which requires twice-daily administration to provide continuous pain relief throughout each day.

Correct Answer: Explain full effect takes up to seventeen hours

fentanyl transdermal patches are not immediate-acting and can take up to seventeen hours to reach full therapeutic effect, so the patient should be counseled about this expected delay in relief. Option a is incorrect because removing and reapplying a new fentanyl patch after only two hours would waste medication and restart the lengthy absorption process without addressing the patient's need for immediate pain relief. Option b is incorrect because increasing the fentanyl patch dose after only two hours would be premature and dangerous since the current patch has not yet reached its full therapeutic effect, risking eventual overdose. Option c is incorrect because switching to a different long-acting opioid is unnecessary when the fentanyl patch simply needs adequate time to reach full effect, and the patient should receive appropriate short-term breakthrough medication instead.

Correct Answer: Advanced age and pulmonary disease

the greatest risk factors for opioid-related death include advanced age over seventy, underlying pulmonary disease including COPD, and being less than twenty-four hours post-surgery, all present in this patient. Option a is incorrect because young age and good lung function are actually protective factors against opioid-related respiratory complications, and represent the opposite of the high-risk profile described for this elderly patient with COPD. Option c is incorrect because while recent surgery is a contributing risk factor, high blood pressure alone is not identified as a primary risk factor for opioid-related death, making this combination less concerning than advanced age with pulmonary disease. Option d is incorrect because gender and cardiac history are not specifically identified as the greatest risk factors for opioid-related death, which are advanced age over seventy and underlying pulmonary conditions like COPD and asthma.

Correct Answer: Lithium toxicity

excessive urination, extreme thirst, vomiting, diarrhea, and tremors are classic toxic signs of lithium, and stomach flu with fluid loss significantly increases toxicity risk due to dehydration. Option a is incorrect because while mild side effects can occur with lithium, the combination of excessive thirst, frequent urination, tremors, and vomiting during an illness causing dehydration strongly suggests lithium toxicity requiring urgent evaluation. Option b is incorrect because the reported symptoms of excessive thirst, urination, tremors, and vomiting are characteristic of lithium toxicity, not a relapse of bipolar disorder, especially in the context of recent illness with fluid loss. Option d is incorrect because although the stomach flu is causing dehydration, dehydration in a lithium patient leads to dangerous drug concentration increases, making lithium toxicity the primary concern rather than simple dehydration alone.

Correct Answer: Do not restrict sodium or fluid intake

lithium and sodium share renal pathways, so restricting sodium or fluids causes the kidneys to retain more lithium, dangerously increasing drug levels and creating a high risk of toxicity. Option b is incorrect because limiting sodium intake in a patient on lithium therapy would decrease sodium excretion and cause the body to retain more lithium, raising drug levels to potentially toxic concentrations rather than improving health. Option c is incorrect because reducing fluid intake would concentrate lithium in the body, directly increasing the risk of toxicity, and patients on lithium should actually maintain adequate hydration to support safe drug levels. Option d is incorrect because sodium restriction at any time during lithium therapy poses a toxicity risk regardless of mood state, since the renal handling of sodium and lithium is constant and not dependent on episode type.

Correct Answer: They increase lithium toxicity risk

nonsteroidal anti-inflammatory drugs reduce renal excretion of lithium, causing drug levels to rise and significantly increasing the risk of lithium toxicity, which is why NSAIDs should be held. Option a is incorrect because NSAIDs do not reduce lithium absorption from the gastrointestinal tract but rather impair the kidneys' ability to excrete lithium, leading to dangerous accumulation and elevated serum drug levels over time. Option b is incorrect because NSAIDs do not neutralize or cancel the therapeutic mood-stabilizing effects of lithium but instead create a dangerous pharmacokinetic interaction that raises lithium blood levels toward toxic ranges. Option c is incorrect because NSAIDs cause the opposite effect of rapid excretion, as they actually decrease renal elimination of lithium, leading to accumulation in the body and increased risk of serious toxicity.

Correct Answer: Emphasize taking lithium every day consistently

lithium must be taken every day in regularly spaced doses without missing any, and patients should not stop taking it even when feeling better, as discontinuation leads to relapse. Option a is incorrect because agreeing with the patient's plan to stop lithium contradicts essential prescribing guidance, since lithium is a long-term treatment that must be continued regardless of symptom improvement to prevent relapse. Option c is incorrect because reducing lithium to every other day would create inconsistent blood levels, increasing the risk of both subtherapeutic drug levels and potential toxicity, and is not a recommended dosing modification. Option d is incorrect because there is no guideline supporting lithium discontinuation after a year of stability, as lithium is intended for long-term continuous therapy and stopping it risks mood destabilization and relapse.

Correct Answer: Hold the dose and notify the provider

a lithium level above one point five milliequivalents per liter indicates toxicity, requiring the nurse to hold the medication immediately and notify the healthcare provider for urgent evaluation and intervention. Option a is incorrect because continuing the current lithium dose when the serum level is one point seven would perpetuate a toxic state, as levels above one point five indicate toxicity requiring immediate dose adjustment or discontinuation. Option b is incorrect because administering another dose of lithium when the current level already exceeds the toxic threshold of one point five would further elevate drug concentrations and worsen the patient's toxic condition. Option d is incorrect because while increasing fluids may support renal lithium clearance, the immediate priority when a toxic level is identified is to hold the medication and notify the provider, not wait an hour to recheck.